| The notes and any shares of Merit’s common stock issuable upon conversion of the notes have not been
and will not be registered under the Securities Act, any state securities laws or the securities laws of any
other jurisdiction, and unless so registered, may not be offered or sold in the United States absent
registration or an applicable exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act and other applicable securities laws. The notes will be offered to persons
reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act.
This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities
(including the shares of Merit’s common stock, if any, into which the notes are convertible) nor shall there
be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would
be unlawful prior to the registration or qualification thereof under the securities laws of any such state or
jurisdiction.
About Merit Medical
Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in
interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology,
critical care and endoscopy. Merit strives to be the most customer-focused company in healthcare. Merit
is determined to make a difference by understanding its customers’ needs and innovating and delivering a
diverse range of products that improve the lives of people and communities throughout the world. Merit
believes that long-term value is created for its customers, employees, shareholders, and communities when
it focuses outward and is determined to deliver an exceptional customer experience.
Forward-Looking Statements
This release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”). All statements in this release, other than statements of historical fact, are “forward-looking
statements” for purposes of these provisions, including any projections of earnings, revenues or other
financial items, any statements of the plans and objectives of Merit’s management for future operations,
any statements regarding the terms, conditions and anticipated financial transactions and outcomes
associated with the notes, any statements concerning proposed new products or services, any statements
regarding the integration, development or commercialization of the business or any assets acquired from
other parties, any statements regarding future economic conditions or performance, and any statements
of assumptions underlying any of the foregoing. In some cases, forward-looking statements can be
identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,”
“seeks,” “believes,” “estimates,” “potential,” “forecasts,” “continue,” or other forms of these words or
similar words or expressions, or the negative thereof or other comparable terminology. Although Merit
believes that the expectations reflected in the forward-looking statements contained herein are
reasonable, there can be no assurance that such expectations or any of the forward-looking statements
will prove to be correct, and actual results will likely differ, and could differ materially, from those projected
or assumed in the forward-looking statements. Important factors that could cause actual results to differ
materially from those indicated in the forward-looking statements related to the offering include risks and |